Gilead Sciences, Inc. (GILD), founded in 1987, has long stood as one of America’s most influential biopharmaceutical powerhouses, a company that built its legacy by tackling humanity’s most complex ...

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus ...

Over the past year or so, Gilead Sciences has gone from Wall Street darling to a battleground stock. This sharp turn in investor sentiment has centered on the company's controversial and ...

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

According to Benzinga Pro, Gilead Sciences Inc's peer group average for short interest as a percentage of float is 6.89%, which means the company has less short interest than most of its peers. Did ...

Investors in Gilead Sciences Inc (Symbol: GILD) saw new options become available today, for the June 13th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GILD ...

Investors in Gilead Sciences Inc (Symbol: GILD) saw new options become available today, for the August 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GILD ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...